Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis

Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity

(2018) D.M. Casa et al.   EXPERIMENTAL PARASITOLOGY

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell

(2018) M. Junaid Dar et al.   DRUG DELIVERY

Efficacy of Apigenin and Miltefosine Combination Therapy against Experimental Cutaneous Leishmaniasis

(2018) Yago S. S. Emiliano et al.   JOURNAL OF NATURAL PRODUCTS

Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa

(2017) M. Junaid Dar et al.   JOURNAL OF DRUG TARGETING

Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis

(2016) Brajendra Tiwari et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection withLeishmania amazonensis

(2016) Cristiana T. Trinconi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model

(2016) Katrien Van Bocxlaer et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action

(2016) Fernanda Fonseca-Silva et al.   PLoS Neglected Tropical Diseases

Combination of elastic liposomes and low frequency ultrasound for skin permeation enhancement of hyaluronic acid

(2015) Chawankorn Kasetvatin et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery

(2015) Donato Cosco et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Uncovering Leishmania–macrophage interplay using imaging flow cytometry

(2015) Cesar Terrazas et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Effect of Apigenin on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction

(2015) Fernanda Fonseca-Silva et al.   JOURNAL OF NATURAL PRODUCTS

Immunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha

(2015) Thais Alves da Costa-Silva et al.   JOURNAL OF NATURAL PRODUCTS

Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: Relevance for drug delivery systems

(2014) Rebuma Firdessa et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: In-vitro optimization, ex-vivo permeation studies, and in-vivo assessment

(2014) Abdulaziz Mohsen Al-mahallawi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Drug delivery: lessons to be learnt fromLeishmaniastudies

(2014) CD Shaw et al.   Nanomedicine

Immunoregulation in human American leishmaniasis: balancing pathology and protection

(2014) K. J. Gollob et al.   PARASITE IMMUNOLOGY

Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: Macrophage as target cell

(2013) Neuza B. Barros et al.   EXPERIMENTAL PARASITOLOGY

Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations

(2013) Eder Romero et al.   International Journal of Nanomedicine

Nano-transfersomes as a novel carrier for transdermal delivery

(2013) Hema Chaudhary et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice

(2012) Neda Bavarsad et al.   ACTA TROPICA

Efficacy of Combined Therapy with Liposome-Encapsulated Meglumine Antimoniate and Allopurinol in Treatment of Canine Visceral Leishmaniasis

(2012) Sydnei M. da Silva et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: Role of TLR4 and TLR9

(2012) Asok Kumar Mukherjee et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives

(2010) Maribel Navarro et al.   DRUG DISCOVERY TODAY

Apigenin inhibits allergen-induced airway inflammation and switches immune response in a murine model of asthma

(2010) Ruo-Ran Li et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery

(2010) Ghada M. El Zaafarany et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Combination therapy for visceral leishmaniasis

(2010) Johan van Griensven et al.   LANCET INFECTIOUS DISEASES

Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent

(2009) Christian Celia et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Liposomes and skin: From drug delivery to model membranes

(2008) G.M. El Maghraby et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release

(2007) Lars H. Lindner et al.   JOURNAL OF CONTROLLED RELEASE